• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四种抗疟联合用药治疗塞内加尔非复杂性恶性疟原虫疟疾的疗效和耐受性

Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.

作者信息

Faye Babacar, Ndiaye Jean-Louis, Ndiaye Daouda, Dieng Yemou, Faye Oumar, Gaye Oumar

机构信息

Laboratoire de Parasitologie-Mycologie, Faculté de Médecine, Pharmacie et Odontologie, Université Cheikh Anta Diop, Dakar, Senegal.

出版信息

Malar J. 2007 Jun 14;6:80. doi: 10.1186/1475-2875-6-80.

DOI:10.1186/1475-2875-6-80
PMID:17570848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1919387/
Abstract

BACKGROUND

In view of the high level of chloroquine resistance in many countries, WHO has recommended the use of combination therapy with artemisinin derivatives in the treatment of uncomplicated malaria due to Plasmodium falciparum. Four antimalarial drug combinations, artesunate plus amodiaquine (Arsucam), artesunate plus mefloquine (Artequin), artemether plus lumefantrine (Coartem; four doses and six doses), and amodiaquine plus sulphadoxine-pyrimethamine, were studied in five health districts in Senegal.

METHODS

This is a descriptive, analytical, open, randomized study to evaluate the efficacy and tolerability of these four antimalarial combinations in the treatment of uncomplicated falciparum malaria using the 2002 WHO protocol.

RESULTS

All drug combinations demonstrated good efficacy. On day 28, all combinations resulted in an excellent clinical and parasitological response rate of 100% after correction for PCR results, except for the four-dose artemether-lumefantrine regimen (96.4%). Follow-up of approximately 10% of each treatment group on day 42 demonstrated an efficacy of 100%.The combinations were well tolerated clinically and biologically. No unexpected side-effect was observed and all side-effects disappeared at the end of treatment. No serious side-effect requiring premature termination of treatment was observed.

CONCLUSION

The four combinations are effective and well-tolerated.

摘要

背景

鉴于许多国家氯喹耐药性水平较高,世界卫生组织已建议使用青蒿素衍生物联合疗法治疗由恶性疟原虫引起的非复杂性疟疾。在塞内加尔的五个卫生区对四种抗疟药物组合进行了研究,即青蒿琥酯加阿莫地喹(Arsucam)、青蒿琥酯加甲氟喹(Artequin)、蒿甲醚加本芴醇(Coartem;四剂和六剂)以及阿莫地喹加磺胺多辛-乙胺嘧啶。

方法

这是一项描述性、分析性、开放性随机研究,采用2002年世界卫生组织方案评估这四种抗疟组合治疗非复杂性恶性疟的疗效和耐受性。

结果

所有药物组合均显示出良好疗效。在第28天,除四剂蒿甲醚-本芴醇治疗方案(96.4%)外,校正PCR结果后所有组合的临床和寄生虫学反应率均达到100%的优异水平。在第42天对每个治疗组约10%的患者进行随访显示疗效为100%。这些组合在临床和生物学上耐受性良好。未观察到意外副作用,且所有副作用在治疗结束时均消失。未观察到需要提前终止治疗的严重副作用。

结论

这四种组合有效且耐受性良好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/007d/1919387/3a6361c71d7a/1475-2875-6-80-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/007d/1919387/266748cbc33b/1475-2875-6-80-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/007d/1919387/3a6361c71d7a/1475-2875-6-80-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/007d/1919387/266748cbc33b/1475-2875-6-80-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/007d/1919387/3a6361c71d7a/1475-2875-6-80-2.jpg

相似文献

1
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.四种抗疟联合用药治疗塞内加尔非复杂性恶性疟原虫疟疾的疗效和耐受性
Malar J. 2007 Jun 14;6:80. doi: 10.1186/1475-2875-6-80.
2
Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.在布基纳法索,阿莫地喹联合磺胺多辛-乙胺嘧啶、蒿甲醚-本芴醇以及双氢青蒿素-哌喹治疗无并发症恶性疟原虫疟疾的随机对照研究
Clin Infect Dis. 2007 Dec 1;45(11):1453-61. doi: 10.1086/522985. Epub 2007 Oct 22.
3
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.在老挝人民民主共和国,氯喹加周效磺胺-乙胺嘧啶与青蒿琥酯加甲氟喹以及蒿甲醚-本芴醇治疗非复杂性恶性疟的随机对照研究
Clin Infect Dis. 2004 Oct 15;39(8):1139-47. doi: 10.1086/424512. Epub 2004 Sep 27.
4
Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa.在西非贝宁海岸,将青蒿琥酯添加到磺胺多辛-乙胺嘧啶中可大大提高单纯性恶性疟患儿的治疗效果。
Malar J. 2007 Dec 21;6:170. doi: 10.1186/1475-2875-6-170.
5
Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.青蒿琥酯-阿莫地喹与氯喹-乙胺嘧啶-磺胺多辛治疗尼日利亚儿童单纯性恶性疟原虫疟疾的开放随机研究
Trop Med Int Health. 2005 Nov;10(11):1161-70. doi: 10.1111/j.1365-3156.2005.01503.x.
6
Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast.青蒿琥酯-阿莫地喹(科泰新)与青蒿琥酯-甲氟喹(科泰复)治疗无并发症恶性疟原虫疟疾的疗效和耐受性:塞内加尔和科特迪瓦多中心试验。
Trop Med Int Health. 2010 May;15(5):608-13. doi: 10.1111/j.1365-3156.2010.02487.x. Epub 2010 Mar 1.
7
Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.青蒿琥酯加阿莫地喹与蒿甲醚-本芴醇治疗坦桑尼亚桑给巴尔单纯性儿童恶性疟的疗效比较
Clin Infect Dis. 2005 Oct 15;41(8):1079-86. doi: 10.1086/444460. Epub 2005 Sep 13.
8
Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.青蒿琥酯加阿莫地喹、青蒿琥酯加磺胺多辛-乙胺嘧啶以及氯喹加磺胺多辛-乙胺嘧啶在科摩罗联盟非复杂性恶性疟患者中的疗效。
Acta Trop. 2007 Jun;102(3):176-81. doi: 10.1016/j.actatropica.2007.03.004. Epub 2007 May 3.
9
A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda.一项评估蒿甲醚-本芴醇(科泰复)治疗卢旺达非复杂性恶性疟原虫疟疾安全性和有效性的随机试验。
Trans R Soc Trop Med Hyg. 2007 Apr;101(4):344-50. doi: 10.1016/j.trstmh.2006.06.010. Epub 2006 Sep 26.
10
A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan.苏丹东部青蒿琥酯联合周效磺胺/乙胺嘧啶与蒿甲醚-本芴醇疗效的比较研究
Malar J. 2007 Jul 15;6:92. doi: 10.1186/1475-2875-6-92.

引用本文的文献

1
Examining the disparities of anti-malarial drug consumption among children under the age of five: a study of 5 malaria-endemic countries.探讨五岁以下儿童抗疟药消费的差异:五个疟疾流行国家的研究。
Malar J. 2023 Dec 5;22(1):370. doi: 10.1186/s12936-023-04805-x.
2
Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria.预测青蒿琥酯-甲氟喹联合治疗敏感和耐药性恶性疟原虫疟疾的抗疟化疗效果的改善。
PLoS One. 2023 Feb 23;18(2):e0282099. doi: 10.1371/journal.pone.0282099. eCollection 2023.
3
[Monitoring the Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated Malaria by Kelch 13 Gene Mutations in Bangui, Central African Republic].

本文引用的文献

1
Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal.塞内加尔恶性疟原虫二氢叶酸还原酶和二氢蝶酸合酶基因的突变
Trop Med Int Health. 2005 Nov;10(11):1176-9. doi: 10.1111/j.1365-3156.2005.01506.x.
2
Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.阿莫地喹单药、阿莫地喹+磺胺多辛-乙胺嘧啶、阿莫地喹+青蒿琥酯以及蒿甲醚-本芴醇用于坦桑尼亚儿童疟疾门诊治疗:一项四臂随机疗效试验。
Lancet. 2005;365(9469):1474-80. doi: 10.1016/S0140-6736(05)66417-3.
3
[通过监测中非共和国班吉地区 Kelch 13 基因突变来评估蒿甲醚-本芴醇治疗非复杂性疟疾的疗效]
Med Trop Sante Int. 2021 Mar 26;1(1). doi: 10.48327/mtsibulletin.n1.2021.82. eCollection 2021 Mar 31.
4
Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data.急性无并发症恶性疟原虫疟疾的血液学后果:全球抗疟网个体化患者数据分析的 pooled 分析。
BMC Med. 2022 Mar 7;20(1):85. doi: 10.1186/s12916-022-02265-9.
5
Novel chloroquine loaded curcumin based anionic linear globular dendrimer G2: a metabolomics study on using H NMR spectroscopy.新型载氯喹姜黄素基阴离子线性球状树枝状大分子 G2:基于~1H NMR 光谱的代谢组学研究。
Parasitology. 2020 Jun;147(7):747-759. doi: 10.1017/S0031182020000372. Epub 2020 Feb 27.
6
Comparison of anti-malarial drugs efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis.使用网状Meta分析比较抗疟药物治疗非洲儿童和成人单纯性疟疾的疗效
Malar J. 2017 Aug 3;16(1):311. doi: 10.1186/s12936-017-1963-0.
7
Malaria in Dielmo, a Senegal village: Is its elimination possible after seven years of implementation of long-lasting insecticide-treated nets?在塞内加尔的迪耶尔莫村:在实施长效驱虫蚊帐七年之后,疟疾能够被消除吗?
PLoS One. 2017 Jul 5;12(7):e0179528. doi: 10.1371/journal.pone.0179528. eCollection 2017.
8
The Relative Effects of Artemether-lumefantrine and Non-artemisinin Antimalarials on Gametocyte Carriage and Transmission of Plasmodium falciparum: A Systematic Review and Meta-analysis.蒿甲醚-本芴醇与非青蒿素类抗疟药对恶性疟原虫配子体携带及传播的相对影响:一项系统评价和荟萃分析
Clin Infect Dis. 2017 Aug 1;65(3):486-494. doi: 10.1093/cid/cix336.
9
West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia.西非疟疾研究国际卓越中心:塞内加尔、马里和冈比亚对蒿甲醚-本芴醇的耐药模式
Am J Trop Med Hyg. 2016 Nov 2;95(5):1054-1060. doi: 10.4269/ajtmh.16-0053. Epub 2016 Aug 22.
10
Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.青蒿琥酯-甲氟喹与蒿甲醚-本芴醇固定剂量复方制剂治疗撒哈拉以南非洲5岁以下儿童单纯性恶性疟的比较:一项随机、多中心、4期试验
Lancet Infect Dis. 2016 Oct;16(10):1123-1133. doi: 10.1016/S1473-3099(16)30020-2. Epub 2016 Jul 16.
A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso.
阿莫地喹与青蒿琥酯单药及联合用药治疗布基纳法索儿童单纯性恶性疟的随机试验。
Trop Med Int Health. 2004 Apr;9(4):438-44. doi: 10.1111/j.1365-3156.2004.01224.x.
4
Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children.乙胺嘧啶-磺胺多辛单独使用或联合阿莫地喹或氯喹治疗乌干达儿童单纯性恶性疟的疗效
Trop Med Int Health. 2004 Feb;9(2):222-9. doi: 10.1046/j.1365-3156.2003.01187.x.
5
Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial.单独使用周效磺胺/乙胺嘧啶或联合阿莫地喹或青蒿琥酯治疗非复杂性疟疾:一项纵向随机试验
Lancet. 2002;360(9350):2031-8. doi: 10.1016/S0140-6736(02)12021-6.
6
The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria.周效磺胺-乙胺嘧啶、阿莫地喹及其联合用药治疗非复杂性恶性疟的安全性和有效性。
Am J Trop Med Hyg. 2002 Jul;67(1):17-23. doi: 10.4269/ajtmh.2002.67.17.
7
Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.周效磺胺-乙胺嘧啶、阿莫地喹及周效磺胺-乙胺嘧啶-阿莫地喹联合用药对喀麦隆幼儿单纯性恶性疟的治疗效果
Bull World Health Organ. 2002;80(7):538-45.
8
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial.阿莫地喹-青蒿琥酯与阿莫地喹治疗非洲儿童非复杂性恶性疟原虫疟疾的疗效比较:一项随机、多中心试验。
Lancet. 2002 Apr 20;359(9315):1365-72. doi: 10.1016/s0140-6736(02)08348-4.
9
Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial.阿莫地喹、磺胺多辛/乙胺嘧啶及联合疗法治疗乌干达坎帕拉单纯性恶性疟:一项随机试验
Lancet. 2001 Aug 4;358(9279):368-74. doi: 10.1016/S0140-6736(01)05557-X.
10
Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.蒿甲醚-本芴醇用于治疗多重耐药恶性疟。
Trans R Soc Trop Med Hyg. 2000 Sep-Oct;94(5):545-8. doi: 10.1016/s0035-9203(00)90082-8.